Keryx Biopharmaceuticals, Inc.

Historical 13F Holders

Symbol
KERX
CUSIP
492515101
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 1 1.00 $3.00
2024 Q4 1 1.00 $3.00
2024 Q3 1 1.00 $3.00
2024 Q2 1 1.00 $3.00
2024 Q1 1 1.00 $3.00
2023 Q4 1 1.00 $3.00
2023 Q3 1 1.00 $3.00
2023 Q2 1 1.00 $3.00
2023 Q1 1 1.00 $3.00
2022 Q4 1 1.00 $3.00
2022 Q3 1 1.00 $0
2022 Q2 1 1.00 $0
2022 Q1 1 1.00 $0
2021 Q4 1 1.00 $0
2021 Q3 1 1.00 $0
2021 Q2 1 1.00 $0
2021 Q1 1 1.00 $0
2020 Q4 1 1.00 $0
2020 Q3 1 1.00 $0
2020 Q2 1 1.00 $0
2020 Q1 1 1.00 $0
2019 Q4 1 1.00 $0
2019 Q3 1 1.00 $0
2019 Q2 1 1.00 $0
2018 Q4 1 1.00 $0
2018 Q3 142 77.2 M $263 M
2018 Q2 150 75.6 M $284 M
2018 Q1 144 76.8 M $314 M
2017 Q4 153 78.0 M $363 M
2017 Q3 150 79.4 M $564 M
2017 Q2 143 79.4 M $574 M
2017 Q1 134 69.2 M $426 M
2016 Q4 139 68.5 M $401 M
2016 Q3 133 67.0 M $355 M
2016 Q2 135 66.4 M $439 M
2016 Q1 148 67.3 M $315 M
2015 Q4 152 75.0 M $379 M
2015 Q3 160 90.7 M $313 M
2015 Q2 178 92.1 M $919 M
2015 Q1 172 93.5 M $1.19 B
2014 Q4 165 76.7 M $1.09 B
2014 Q3 160 78.0 M $1.07 B
2014 Q2 151 68.3 M $1.05 B
2014 Q1 165 67.2 M $1.14 B